In 2021, the global market for hemodialysis and peritoneal dialysis was valued at USD 17 billion. AMR Group predicts that the market would reach US$ 24 billion by 2031, increasing at a CAGR of 6.3% between 2022 and 2031.
This market expansion is linked to an increase in the frequency of kidney-related disorders and complications connected with kidney transplants, as kidney transplantation requires a major operation, a donor match, and a lifetime regimen of immunosuppressive drugs to keep the body from rejecting the organ. Furthermore, the increasing prevalence of lifestyle and chronic diseases like as obesity, diabetes, and hypertension is expected to boost worldwide hemodialysis and peritoneal dialysis market growth.
However, an increase in problems associated with dialysis treatment, such as infections, hypotension, fluid overload, and access point bleeding, is expected to impede market expansion in the coming years. Similarly, reimbursement policy concerns in emerging nations restrict industry growth. This is because reimbursement for dialysis varies greatly in terms of volume and duration between nations, and does not always cover actual treatment expenses, discouraging patients and physicians from considering policy utilization. On the other hand, a shift in patient preference for home hemodialysis (HHD) due to its effective and patient-centered approach, as well as an increase in market strategies such as acquisitions, partnerships, product development, and innovation by key players, are expected to provide profitable opportunities for market growth during the forecast period.
Request a sample copy of the report – https://wemarketresearch.com/sample-request/hemodialysis-and-peritoneal-dialysis-market/910
Key Players
- Allmed Medical Care Holdings Limited
- Angiodynamics Inc.
- Asahi Kasei Medical Co., Ltd.
- Atlantic Biomedical
- Baxter International Inc.
- C. R. Bard, Inc.
- B. Braun Melsungen Ag
- Cook Group
- DaVita Inc.
- Dialifegroup
- Diaverum
- Fresenius SE and Co. KGAA
- Isopure Corp.
- JMS Co. Ltd.
- Mar Cor Purification
- Medtronic Plc.
- Nikkiso Co. Ltd.
- Nipro Corporation
- Nxstage Medical, Inc.
- Rockwell Medical
Regional Trend
North America dominated the Hemodialysis and Peritoneal Dialysis market, accounting for 89% of total revenue in 2021. The increasing frequency of chronic renal disease, as well as Medicare’s healthcare spending, are driving market expansion in this area. A well-developed and growing R&D, as well as the increasing acceptance of technological advancements in infusion pumps, have all contributed to the rise of hemodialysis and peritoneal dialysis in this region.
The United States had the largest market share in the North American Hemodialysis and Peritoneal Dialysis market due to increased illness prevalence, significant medical R&D spending, and a solid healthcare system. The rise in instances of renal failure in the United States is also a significant cause; more than 500,000 patients have undergone dialysis, and over 200,000 people are living with kidney transplants, which can be connected to their lifestyle and stressful work environment. Over the projection period, the Asia Pacific region is expected to grow significantly. A growing proportion of Asians suffer from chronic diseases such as cancer, diabetes, and dialysis. Asian countries with developing economies, such as Japan, China, and India, have built healthcare infrastructure and facilities.
Growth Driver
Chronic kidney disease (CKD) damages the kidneys, making them less effective in removing waste from the blood than healthy kidneys. Ineffective kidneys cause the body to accumulate toxic waste and excess fluid, which can lead to high blood pressure, heart disease, stroke, and premature death. Those who have CKD or are at risk of developing it, on the other hand, can work with their doctors to take precautions to protect their kidneys.
The frequency of CKD has skyrocketed, fueling the demand for quick-access renal facilities. According to the CDC, chronic kidney disease affects 15% of adults in the United States, or around 37 million individuals. In the United States, 37 million adults have CKD, accounting for 15% of the total population. Up to 90% of CKD patients are ignorant of their illness. Approximately 25% of people with severe CKD are unaware of their disease.
Furthermore, the availability of highly qualified nephrologists has led to an increase in the number of renal care centers in developed countries. Furthermore, investors are focusing more on establishing renal treatment facilities in countries such as India, China, and Mexico to fulfill the rising need for renal care in emerging economies. This is expected to boost the market revenue generation for hemodialysis in the next years. The number of visits to these facilities is increasing as a result of the accessible healthcare that these countries offer.
Buy Now Hemodialysis and Peritoneal Dialysis Market Report – https://wemarketresearch.com/purchase/hemodialysis-and-peritoneal-dialysis-market/910?license=single
About We Market Research
We Market Research is a leading provider of comprehensive market research solutions that assist businesses in making informed decisions and staying ahead of the competition in today’s ever-changing marketplace. With our extensive knowledge and cutting-edge methods, we assist our customers in gaining deep insights into their target markets, consumers, and competitors.
Our firm understands that great business strategies are based on accurate and actionable data. That is why we specialize in conducting in-depth research and analysis across several industries, enabling our clients to identify market trends, assess demand and supply dynamics, and identify development opportunities.
Contact us
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
